(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BEVALTIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BEVALTIA

ST13

US500000097758949

Class

5

Filing

97758949

Registration

7202066

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

05/16/2026

Trademark type

Word

Nice classes

5

Filing date

01/18/2023

Registration date

10/24/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/24/2023

Last transaction

05/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

Durham, NC, US

Examiner

SANGID, HANA RONNY

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

PRIOVANT THERAPEUTICS, INC.
Roivant Sciences GmbH

Representatives

Lisa L. Mueller Casimir Jones, S.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations to treat Crohn's Disease for human use; biologic preparations for medical and therapeutic purposes to treat Chron's diseaseinflammatory diseases and disordersdiseases and disorders of the immune systemdermatomyositissystemic lupus erythematosus (SLE)hidradenitis suppurativasclerodermasarcoidosisjuvenile dermatomyositisnon-infectious uveitis; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositissystemic lupus erythematosus (SLE)hidradenitis suppurativasclerodermasarcoidosisjuvenile dermatomyositisnon-infectious uveitis

Publications

History of USPTO decisions and trademark events.

23 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/14/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/14/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/14/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/01/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/01/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/01/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/01/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/01/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/24/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/24/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/08/2023

PUBO

PUBLISHED FOR OPPOSITION

08/08/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/19/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

07/06/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

06/30/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/29/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

06/29/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/29/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

06/29/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/29/2023

DOCK

ASSIGNED TO EXAMINER

05/31/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/24/2023

NWAP

NEW APPLICATION ENTERED

01/21/2023

Continuous trademark protection

Get notified about every new filing that threatens BEVALTIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.